Zobrazeno 1 - 10
of 415
pro vyhledávání: '"Hurthle cell carcinoma"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Meihua Jin, Eun Sook Kim, Bo Hyun Kim, Hee Kyung Kim, Yea Eun Kang, Min Ji Jeon, Tae Yong Kim, Ho-Cheol Kang, Won Bae Kim, Young Kee Shong, Mijin Kim, Won Gu Kim
Publikováno v:
Endocrinology and Metabolism, Vol 36, Iss 5, Pp 1078-1085 (2021)
Background Hürthle cell carcinoma (HCC), a type of thyroid carcinoma, is rare in South Korea, and few studies have investigated its prognosis. Methods This long-term multicenter retrospective cohort study evaluated the clinicopathological features a
Externí odkaz:
https://doaj.org/article/9b6ff342134e4302b522c3eace43c6de
Autor:
Richard David Blossey, Dennis Kleine-Döpke, Kristina Imeen Ringe, Daniel Pöhnert, Bastian Ringe, Jürgen Klempnauer, Oliver Beetz
Publikováno v:
Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-6 (2021)
Abstract Background Follicular thyroid carcinoma is the second most common malignancy of the thyroid gland. In 2016, the so-called Hurthle cell thyroid carcinoma, formerly known as the oxyphilic variant of the follicular thyroid carcinoma, was reclas
Externí odkaz:
https://doaj.org/article/a367ff45dc8d433d9cb4d0d67c1f3087
Autor:
Xingtong Zhou, Zhibo Zheng, Chuyan Chen, Bangbo Zhao, Hongtao Cao, Tianhao Li, Xudong Liu, Weibin Wang, Yongning Li
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Thyroid Hurthle cell carcinoma (HCC) is a rare disease with high risk of invasion and metastasis and poor prognosis. The clinical characteristics, prognosis and treatment of HCC are still controversial, and clinical data are still
Externí odkaz:
https://doaj.org/article/ada1159a014c4a21955823ceae7f8a7d
Publikováno v:
Acta Oto-Laryngologica Case Reports, Vol 5, Iss 1, Pp 74-80 (2020)
Hurthle cell carcinoma is a rare subtype of follicular thyroid carcinoma. Its aggressive nature and poor prognosis require prompt diagnosis and treatment, which is often challenging. We herein report a case of a woman who complained of lumps on her l
Externí odkaz:
https://doaj.org/article/900d7e43ae2d41229e8f33e209eebeec
Publikováno v:
Iranian Journal of Pathology, Vol 14, Iss 4, Pp 342-346 (2019)
The most usual form of the endocrine carcinoma is thyroid cancer (TC). In addition to papillary thyroid carcinoma (PTC), recent studies revealed incidence of RET/PTC rearrangement in other tumors, like Hürthle cell carcinoma (HCC) and even in non-ca
Externí odkaz:
https://doaj.org/article/26e33d86c4a247749fa7adc1d50ff428
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Branisav Oluic, Ivan Paunovic, Zlatibor Loncar, Vladimir Djukic, Aleksandar Diklic, Milan Jovanovic, Zeljko Garabinovic, Nikola Slijepcevic, Branislav Rovcanin, Dusan Micic, Aleksandar Filipovic, Vladan Zivaljevic
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-11 (2017)
Abstract Background Hurthle cell carcinoma makes up 3 to 5% of all thyroid cancers and is considered to be a true rarity. The aim of our study was to analyze clinical characteristics and survival rates of patients with Hurthle cell carcinoma. Methods
Externí odkaz:
https://doaj.org/article/da675f14829640748d9bf67d083e4fe9
Publikováno v:
Acta Oto-Laryngologica Case Reports, Vol 5, Iss 1, Pp 74-80 (2020)
Hurthle cell carcinoma is a rare subtype of follicular thyroid carcinoma. Its aggressive nature and poor prognosis require prompt diagnosis and treatment, which is often challenging. We herein report a case of a woman who complained of lumps on her l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38af4be8a48da8f759623a61687d098d
https://doi.org/10.1080/23772484.2020.1838285
https://doi.org/10.1080/23772484.2020.1838285